Hypoglycemic agents

Details Hypoglycemic agents Hypoglycemic agents

1995-01-09

1996-10-22

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514422, A61K 31445, A61K 3140

Patent

active

055677134

ABSTRACT:
The present invention provides a method for treating hyperglycemia in mammals by administering an antiestrogen compound and pharmaceutically acceptable salts and solvates thereof.

REFERENCES:
patent: 2914563 (1959-11-01), Allen et al.
patent: 3274213 (1966-09-01), Lednicer et al.
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4323707 (1983-04-01), Suarez et al.
patent: 4400543 (1983-08-01), Suarez et al.
patent: 4418068 (1983-11-01), Jones
patent: 4536516 (1985-08-01), Harper et al.
patent: 4729999 (1988-03-01), Young
patent: 4894373 (1990-01-01), Young
patent: 4970237 (1990-11-01), Jensen et al.
Williams, et al., Journal of Bone and Mineral Research, 6 (1991).
FDC Reports, T&G 11, Mar. 30, 1992.
Jones, et al., J. Med. Chem., 27, 1057-1066 (1984).
Feldmann, et al., Bone and Mineral, 7, 245-254 (1989).
"Tamoxifen Trial Restricted", SCRIP No. 1702 Mar. 20, 1992, p. 22.
Jordan, et al., Breast Cancer Research Treatment, 10:31-35 (1987).
Beall, et al., Calcif Tissue Int., 36: 123-125 (1984).
Turner, et al., Journal of Bone and Mineral Research, 2, No. 5, 449-456 (1987).
Williams, et al., Bone and Mineral, 14, 205-220 (1991).
Turner, et al., Endocrinology, 122, No. 3, 1146-1150 (1988).
Love, et al., The New England Journal of Medicine, 326, No. 13, 852-856 (1992).
Breckenridge, et al., Lipids, 22, No. 7, 505-512 (1987).
Lazier, et al., Biochem. Cell Biol., 68, 210-217 (1990).
Lobo, J. Clin. Endocrinol. Metab., 73, No. 5, 925-930 (1991).
Love, et al., Ann. Intern. Med., 115, No. 11, 860-864 (1991).
Walsh, et al., N. Engl. J. Med., 325, No. 17, 1196-1204 (1991).
Bagdade, et al., J. Clin. Endocrinol. Metab., 70, No. 4, 1132-1135 (1990).
Love, et al., J. Natl. Cancer Inst., 82, No. 16, 1327-1332 (1990).
Teo, et al., J. Med. Chem., 35, 1330-1339 (1992).
Cypriani, et al., J. Steroid Biochem., 31, No. 5, 763-771 (1988).
Cypriani, et al., Chemical Abstracts, CA 110: 1189 v, 1989.
Cypriani, et al., Chemical Abstracts, 110:69550v, 1989.
American Chemical Society, Registry, RN# 63676-25-5 (1985).
Nishino, et al., J. of Endocrinology, 130, 409-414 (1991).
Wakeling, et al., J. of Endocrinology, 112, R7-R10 (1987).
Arai, et al., Jpn. J. Vet. Sci., 51, 823-826 (1989).
Dubuc, Proc. Soc. Exp. Biol. Med., 180, 468-473 (1985).
Garris, Anat. Rec., 225, 310-317 (1989).
Cagnacci, et al., J. Clin. Endocrinol. Metab., 74, 1396-1400 (1992).
Saeed, et al., J. Med. Chem., 33, 3210-3216 (1990).
Sharma, et al., J. Med. Chem., 33, 3216-3222 (1990).
Sharma, et al., J. Med. Chem., 33, 3222-3229 (1990).
Ogawa, et al., Chem. Pharm. Bull., 39, 911-916 (1991).
von Angerer, et al., J. Med. Chem., 33, 2635-2640 (1990).
Teo, et al., J. Chem. Reearch (5), 4-5 (1990).
Draper, et al., Abstract for Presentation at 4th International Symposium on Osteoporosis and Consensus Development Conference, Hong Kong, Mar. 27, 1993.
Bjorntorp, Ann. N.Y. Acad. Sci, 676, 242-252 (1993).
Wade, et al., Am. J. Physiol, 264 (Regulatory Integrative Comp. Physiol. 33): R1219-R1223 (1993).
Gray, et al., Am. J. Physiol., 264 (Regulatory Integrative Comp. Physiol. 33): R1214-R1218 (1993).
Gray, et al., Am. J. Physiol., 243, (Endocrinol. Metab. 6): E407-E412 (1992).
Gray, et al., Am. J. Physiol., 240 (Endocrinol. Metab. 3): E474-E481 (1981) .

Affiliated with

Also associated with

Rating

Hypoglycemic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hypoglycemic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2358879